Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Lechner

Showing results (441-450 of 478) with videos related to

Pageof 48
Sort By:
Bone Marrow Transplantation|October 31, 2002
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantationN Worel, D Biener, P Kalhs, et al.
Thrombosis and Haemostasis|April 22, 1985
HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDST L Chorba, J M Jason, R B Ramsey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999
The mast cell as site of tissue-type plasminogen activator expression and fibrinolysisC Sillaber, M Baghestanian, D Bevec, et al.
Blood|November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaE Archimbaud, O G Ottmann, J A Yin, et al.
Blood|December 12, 2001
Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cellsG H Schernthaner, J H Jordan, M Ghannadan, et al.
Wiener Klinische Wochenschrift|April 29, 1998
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosisF Wimazal, S Walchshofer, M Baghestanian, et al.
Annals of Hematology|May 10, 2003
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromesA Berer, E Jäger, V Sagaster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cellH Agis, M Willheim, W R Sperr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot studyK Laczika, M Novak, B Hilgarth, et al.
Bone Marrow Transplantation|January 23, 1999
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemiaE Reiter, H T Greinix, S Brugger, et al.
Pageof 48

Showing results (441-450 of 478) with videos related to

Sort By:
Pageof 48
Bone Marrow Transplantation|October 31, 2002
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantationN Worel, D Biener, P Kalhs, et al.
Thrombosis and Haemostasis|April 22, 1985
HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDST L Chorba, J M Jason, R B Ramsey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999
The mast cell as site of tissue-type plasminogen activator expression and fibrinolysisC Sillaber, M Baghestanian, D Bevec, et al.
Blood|November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaE Archimbaud, O G Ottmann, J A Yin, et al.
Blood|December 12, 2001
Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cellsG H Schernthaner, J H Jordan, M Ghannadan, et al.
Wiener Klinische Wochenschrift|April 29, 1998
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosisF Wimazal, S Walchshofer, M Baghestanian, et al.
Annals of Hematology|May 10, 2003
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromesA Berer, E Jäger, V Sagaster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cellH Agis, M Willheim, W R Sperr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot studyK Laczika, M Novak, B Hilgarth, et al.
Bone Marrow Transplantation|January 23, 1999
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemiaE Reiter, H T Greinix, S Brugger, et al.
Pageof 48